Latest / Cleveland Clinic Cancer Advances
Exploring VISTA and LRIG1 Interactions: Cancer Immunotherapy
Lily Wang, PhD, from the Department of Translational Hematology Oncology Research at Cleveland Clinic, joins the Cancer Advances Podcast to dive into her research on VISTA and LRIG1 interactions. Dr. Wang, an expert in immune mechanisms within cancer, discusses her lab's innovative work on these immune checkpoint proteins and their potential to overcome current treatment limitations. Discover how targeting the VISTA-LRIG1 axis could offer new strategies for tackling resistant tumors and improving patient outcomes.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.